EA200800455A1 - Антибактериальные производные хинолина - Google Patents

Антибактериальные производные хинолина

Info

Publication number
EA200800455A1
EA200800455A1 EA200800455A EA200800455A EA200800455A1 EA 200800455 A1 EA200800455 A1 EA 200800455A1 EA 200800455 A EA200800455 A EA 200800455A EA 200800455 A EA200800455 A EA 200800455A EA 200800455 A1 EA200800455 A1 EA 200800455A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
pharmaceutically acceptable
treatment
forms
bacterial
Prior art date
Application number
EA200800455A
Other languages
English (en)
Other versions
EA015617B1 (ru
Inventor
Жером Эмиль Жорж Гийемон
Давид Франсис Ален Лансуа
Элизабет Терез Жанн Паскье
Кунрад Йозеф Лодевейк Марсель Андрис
Анил Коул
Original Assignee
Янссен Фармацевтика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармацевтика Н.В. filed Critical Янссен Фармацевтика Н.В.
Publication of EA200800455A1 publication Critical patent/EA200800455A1/ru
Publication of EA015617B1 publication Critical patent/EA015617B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/47042-Quinolinones, e.g. carbostyril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

Настоящее изобретение относится к новым замещенным производным хинолина по общей формуле (Ia) или формуле (Ib), их фармацевтически приемлемым кислотно-аддитивным или основно-аддитивным солям, их четвертичным аминам, их стереохимически изомерным формам, их таутомерным формам и их N-оксидным формам. Заявляемые соединения пригодны для использования при лечении бактериального заболевания, в том числе микобактериального заболевания, в частности таких заболеваний, которые вызываются патогенными микобактериями, такими как Mycobacterium tuberculosis, M. bovis, M. avium и М. marinum. Заявляется также композиция, содержащая фармацевтически приемлемый носитель и, в качестве активного ингредиента, терапевтически эффективное количество заявляемых соединений, применение заявляемых соединений или композиций для приготовления лекарственного средства, предназначенного для лечения бактериальных заболеваний, и способ получения заявляемых соединений.
EA200800455A 2005-07-28 2006-07-26 Антибактериальные производные хинолина EA015617B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05106962 2005-07-28
PCT/EP2006/064656 WO2007014885A1 (en) 2005-07-28 2006-07-26 Antibacterial quinoline derivatives

Publications (2)

Publication Number Publication Date
EA200800455A1 true EA200800455A1 (ru) 2008-10-30
EA015617B1 EA015617B1 (ru) 2011-10-31

Family

ID=35610159

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200800455A EA015617B1 (ru) 2005-07-28 2006-07-26 Антибактериальные производные хинолина

Country Status (31)

Country Link
US (1) US7915292B2 (ru)
EP (1) EP1912948B1 (ru)
JP (1) JP5100647B2 (ru)
KR (1) KR101334719B1 (ru)
CN (1) CN101273016B (ru)
AP (1) AP2322A (ru)
AR (1) AR054587A1 (ru)
AU (1) AU2006274918B2 (ru)
BR (1) BRPI0614122B8 (ru)
CA (1) CA2614981C (ru)
CY (1) CY1117247T1 (ru)
DK (1) DK1912948T3 (ru)
EA (1) EA015617B1 (ru)
ES (1) ES2554924T3 (ru)
HK (1) HK1122804A1 (ru)
HR (1) HRP20151308T1 (ru)
HU (1) HUE026259T2 (ru)
IL (1) IL188987A0 (ru)
JO (1) JO3077B1 (ru)
MX (1) MX2008001219A (ru)
MY (1) MY148219A (ru)
NO (1) NO341795B1 (ru)
NZ (1) NZ565946A (ru)
PL (1) PL1912948T3 (ru)
PT (1) PT1912948E (ru)
RS (1) RS54382B1 (ru)
SI (1) SI1912948T1 (ru)
TW (1) TWI427065B (ru)
UA (1) UA94051C2 (ru)
WO (1) WO2007014885A1 (ru)
ZA (1) ZA200800783B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080076924A1 (en) * 2006-06-30 2008-03-27 Patrick Betschmann Piperazines as P2X7 antagonists
EP2571851A1 (en) * 2010-05-21 2013-03-27 Syngenta Participations AG Novel amides as fungicides
WO2013160431A1 (en) 2012-04-27 2013-10-31 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
DK2841425T3 (en) 2012-04-27 2016-06-27 Janssen Pharmaceutica Nv ANTIBACTERIAL QUINOLIN DERIVATIVES
JP6258937B2 (ja) * 2012-08-24 2018-01-10 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 新規二環式ピリジン誘導体
CN104650054B (zh) * 2013-11-25 2019-09-13 重庆医药工业研究院有限责任公司 一种抗结核菌的喹啉噻吩芳氧乙胺衍生物
CN105175329B (zh) * 2014-06-10 2017-09-19 重庆圣华曦药业股份有限公司 一种贝达喹啉消旋体的合成路线及方法
WO2018126115A1 (en) * 2016-12-30 2018-07-05 Board Of Regents, The University Of Texas System Quaternary amine antibiotic therapeutics
CN110804016B (zh) * 2019-12-05 2022-11-04 福建省微生物研究所 抗结核分枝杆菌的二芳基喹啉衍生物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1041035A3 (ru) * 1982-02-25 1983-09-07 Киорин Сейяку Кабусики Кайся (Фирма) Способ получени производных хинолинкарбоновой кислоты,их гидратов или солей
JPS6463518A (en) * 1987-09-02 1989-03-09 Otsuka Pharma Co Ltd Antiarrhythmic agent
US5235054A (en) * 1992-07-15 1993-08-10 Pfizer Inc. 3-carboxaldehyde substituted quinolines and naphthyridines
BR9507672A (pt) * 1994-05-24 1997-08-19 Hoffmann La Roche Derivados tricíclicos de dicarbonila
HUP0103093A3 (en) * 1998-04-29 2002-03-28 Smithkline Beecham Plc Quinolones used as mrs inhibitors and bactericides and process for their preparation
SI2301544T1 (sl) 2002-07-25 2013-01-31 Janssen Pharmaceutica, N.V. Derivati kinolina kot vmesne spojine za mikobakterijske inhibitorje

Also Published As

Publication number Publication date
DK1912948T3 (en) 2016-01-18
IL188987A0 (en) 2008-08-07
EA015617B1 (ru) 2011-10-31
AU2006274918A1 (en) 2007-02-08
SI1912948T1 (sl) 2016-01-29
KR101334719B1 (ko) 2013-11-29
CN101273016A (zh) 2008-09-24
WO2007014885A1 (en) 2007-02-08
HUE026259T2 (en) 2016-06-28
HRP20151308T1 (hr) 2016-01-01
AU2006274918B2 (en) 2011-09-22
JP2009502869A (ja) 2009-01-29
JP5100647B2 (ja) 2012-12-19
BRPI0614122B8 (pt) 2023-01-10
UA94051C2 (ru) 2011-04-11
NZ565946A (en) 2010-11-26
CY1117247T1 (el) 2017-04-05
MY148219A (en) 2013-03-29
RS54382B1 (en) 2016-04-28
ES2554924T3 (es) 2015-12-28
CA2614981A1 (en) 2007-02-08
TW200800901A (en) 2008-01-01
EP1912948B1 (en) 2015-09-09
PT1912948E (pt) 2015-12-21
MX2008001219A (es) 2008-03-24
US20080182855A1 (en) 2008-07-31
NO20081008L (no) 2008-02-27
EP1912948A1 (en) 2008-04-23
NO341795B1 (no) 2018-01-22
CN101273016B (zh) 2013-01-02
CA2614981C (en) 2014-06-03
AR054587A1 (es) 2007-06-27
JO3077B1 (ar) 2017-03-15
AP2322A (en) 2011-11-18
PL1912948T3 (pl) 2016-02-29
BRPI0614122A2 (pt) 2011-03-09
KR20080031973A (ko) 2008-04-11
BRPI0614122B1 (pt) 2020-09-24
TWI427065B (zh) 2014-02-21
US7915292B2 (en) 2011-03-29
ZA200800783B (en) 2009-06-24
HK1122804A1 (en) 2009-05-29
BRPI0614122A8 (pt) 2019-01-29

Similar Documents

Publication Publication Date Title
EA200800455A1 (ru) Антибактериальные производные хинолина
MXPA05001052A (es) Derivados de quinolina y su uso como inhibidores micobacterianos.
EA200602260A1 (ru) Применение замещенных хинолиновых производных для лечения заболеваний, вызываемых микобактериями, резистентными к лекарственным средствам
EA200601364A1 (ru) Производные хинолина и их применение в качестве ингибиторов микобактерий
EA200970535A1 (ru) Антибактериальные производные хинолина
NO20063747L (no) Substituerte kinoliner og deres anvendelse som mykobakterielle inhibitorer
EA200970534A1 (ru) Антибактериальные производные хинолина
CY1112230T1 (el) Αντιβακτηριακα παραγωγα κινολινης
ZA202203107B (en) Azaindole carboxamide compounds for the treatment of mycobacterial infections
EA200500500A1 (ru) Новые антимикобактериальные соединения
CY1114384T1 (el) Αντιβακτηριακα παραγωγα κινολινης
JO2685B1 (en) Quinoline antibacterial derivatives
CY1112027T1 (el) Αντιβακτηριακα παραγωγα κινολινης
TH78309B (th) สารยับยั้งมายคอแบคทีเรียชนิดใหม่
TH101189A (th) อนุพันธ์ควิโนลีนต่อต้านแบคทีเรีย